| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1991) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | J01MA04 |
| UNII: | 325OGW249P |
| InChI Key | IDYZIJYBMGIQMJ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H17FN4O3 |
| Molecular Weight | 320.32 |
| AlogP | 0.66 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 87.46 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 23.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 10000 | - | - | - | |
|
Enzyme
Isomerase
|
- | 14000 | - | - | - | |
|
Other nuclear protein
|
- | - | 94 | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 111 | |
|
Transporter
Primary active transporter
F-type and V-type ATPases
V-type ATPase
|
- | 10000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Amyotrophic Lateral Sclerosis | 1 | D000690 | ClinicalTrials |
| Osteomyelitis | 0 | D010019 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 74011-58-8 |
| ChEBI | 157175 |
| ChEMBL | CHEMBL826 |
| DrugBank | DB00467 |
| DrugCentral | 1013 |
| EPA CompTox | DTXSID5022984 |
| FDA SRS | 325OGW249P |
| Human Metabolome Database | HMDB0014610 |
| Guide to Pharmacology | 8882 |
| KEGG | C06979 |
| PharmGKB | PA449462 |
| PubChem | 3229 |
| SureChEMBL | SCHEMBL33963 |
| ZINC | ZINC000019594549 |